CN Patent

CN105640961A — 一种含依鲁替尼的药物组合物

Assigned to Shandong Ruihe Pharmaceutical R&d Co Ltd · Expires 2016-06-08 · 10y expired

What this patent protects

本发明涉及一种含依鲁替尼的药物组合物，其活性组分为依鲁替尼，其特点是选择中长链的饱和或不饱和脂肪酸、取代羧酸等可药用有机酸或其中一个或多个酸的混合物或鱼油作为亲油性组分，根据各剂型的不同要求，可不加入或加入适当的水制成亲水基质，该组合物的配方可适用于软胶囊、软膏剂、滴眼剂、口服液及注射剂等剂型的制备。

USPTO Abstract

本发明涉及一种含依鲁替尼的药物组合物，其活性组分为依鲁替尼，其特点是选择中长链的饱和或不饱和脂肪酸、取代羧酸等可药用有机酸或其中一个或多个酸的混合物或鱼油作为亲油性组分，根据各剂型的不同要求，可不加入或加入适当的水制成亲水基质，该组合物的配方可适用于软胶囊、软膏剂、滴眼剂、口服液及注射剂等剂型的制备。

Drugs covered by this patent

Patent Metadata

Patent number
CN105640961A
Jurisdiction
CN
Classification
—
Expires
2016-06-08
Drug substance claim
No
Drug product claim
No
Assignee
Shandong Ruihe Pharmaceutical R&d Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.